# Michael List

> Michael List is a seed investor at GreenSky Ventures backing Machine Learning. See 12 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [GreenSky Ventures](https://shizune.co/investors/profile/greensky-capital)
- Location: Toronto, Canada
- Total investments: 12
- Last investment: Oct 2023
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/michael-t-r-list-31957929/

Michael List is a seed investor at GreenSky Ventures in Toronto focused on Machine Learning and Artificial Intelligence. Michael is both a partner at GreenSky Capital and a partner and practicing lawyer at Ormston List Frawley LLP, where his practice focuses on providing corporate, commercial and transactional advice. In the early 2000s, Michael co-founded and served as Chief Operating Officer of a multi-national computer hardware distributor. In the late 2000s, hewas a co-founder and Chief Operating Officer of a private Canadian currency exchange brokerage which was sold two and a half years after its inception. Michael is also currently a director and General Counsel of Smart Energy Instruments, an international fabless semi-conductor company.Michael has a B.A.H. from Queen’s University and an LL.B. from Queen’s University. Michael was called to the bar of the Law Society of Upper Canada in 2000.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Machine Learning | 2 | 17% |
| Artificial Intelligence | 2 | 17% |
| SaaS | 1 | 8% |
| Sensor | 1 | 8% |
| Medical | 1 | 8% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 33% |
| Series A | 2 | 17% |
| Series B | 1 | 8% |
| Funding Round | 1 | 8% |
| Debt Financing | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brickeye | AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments andheavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently. | $3.6M | Debt Financing | Oct 31, 2023 |  |
| Mission Control Space Services Inc. | Mission Control is a space exploration and robotics company specializing in spacecraft operations, onboard autonomy and artificial intelligence. We are developing a full-stack robotic control solution. Our technology is designed to control and automate robotic assets operating in harsh and remote environments and increase the safety, efficiency andscientific or financial return of missions. | $3.3M | Seed | Sep 07, 2023 |  |
| Wisedocs | Wisedocs offers a machine-learning SaaS platform for insurance, legal, and independent medical evaluation firms to review medical records with ease. It was created to help the IME, diagnostics, medico-legal, and insurance industries organize and understand unstructured medical data. The company caters to the auto, liability, disability,workers' compensation, tort law, and similar markets. It offers an easy-to-integrate solution that enhances accuracy and speed to improve outcomes in processing medical records. | $3.2M | Seed | Mar 17, 2022 |  |
| Cyclica | Cyclica is the partner of choice for data-driven drug discovery. The software developed by the company uses biophysics and artificial intelligence (AI) to improve drug discovery practices by generating a list of putative ligand-protein interactions, allowing health institutions to prioritize lead candidates, elucidate adverse effects, andunderstand repurposing opportunities. | $16.9M | Series B | Jun 24, 2020 |  |
| Cyclica | Cyclica is the partner of choice for data-driven drug discovery. The software developed by the company uses biophysics and artificial intelligence (AI) to improve drug discovery practices by generating a list of putative ligand-protein interactions, allowing health institutions to prioritize lead candidates, elucidate adverse effects, andunderstand repurposing opportunities. |  |  | Jul 01, 2019 |  |
| Brickeye | AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments andheavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently. | $3.2M | Series A | Dec 31, 2018 |  |
| Cyclica | Cyclica is the partner of choice for data-driven drug discovery. The software developed by the company uses biophysics and artificial intelligence (AI) to improve drug discovery practices by generating a list of putative ligand-protein interactions, allowing health institutions to prioritize lead candidates, elucidate adverse effects, andunderstand repurposing opportunities. | $2.3M | Series A | Jul 26, 2017 |  |
| Brickeye | AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments andheavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently. | $675K | Seed | Feb 15, 2017 |  |
| Brickeye | AOMS Technologies provides integrated Industrial IoT platforms for generating actionable insights from assets and processes to enhance efficiency and productivity, reduce operation costs, increase safety, and improve environmental sustainability. AOMS IoT platforms are integrated sensors and analytics tools developed for harsh environments andheavy industrial applications where conventional technologies fail, lose performance, or cannot be deployed efficiently. |  | Seed | Dec 12, 2016 |  |
| Cyclica | Cyclica is the partner of choice for data-driven drug discovery. The software developed by the company uses biophysics and artificial intelligence (AI) to improve drug discovery practices by generating a list of putative ligand-protein interactions, allowing health institutions to prioritize lead candidates, elucidate adverse effects, andunderstand repurposing opportunities. | $2.4M | Series A | Sep 22, 2016 |  |

10 of 12 investments shown.

## Co-investors
- [Brightspark Ventures](https://shizune.co/investors/profile/brightspark-ventures) — VC Fund, 2 deals together
- [Export Development Canada](https://shizune.co/investors/profile/export-development-canada) — VC Fund, 2 deals together
- [MaRS Investment Accelerator Fund](https://shizune.co/investors/profile/mars-investment-accelerator-fund) — VC Fund, 2 deals together
- [BDC Capital Corporation](https://shizune.co/investors/profile/bdc-capital-corporation) — VC Fund, 1 deal together
- [Chiesi Pharmaceuticals](https://shizune.co/investors/profile/chiesi-pharmaceuticals) — VC Fund, 1 deal together
- [Drive Capital](https://shizune.co/investors/profile/drive-capital) — VC Fund, 1 deal together

## About GreenSky Ventures

VC Fund · Toronto, Canada

GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.

5 contacts available at GreenSky Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Anton Neschadim | Senior Analyst | https://shizune.co/investors/profile/anton-neschadim |
| Gregory Stewart | Managing Partner | https://shizune.co/investors/profile/greg-stewart |
| James Brink | Chief Compliance Officer | https://shizune.co/investors/profile/james-brink |
| Michael List | Founder and Managing Partner | https://shizune.co/investors/profile/michael-t-r-list |
| Moien Giashi | Associate | https://shizune.co/investors/profile/moien-giashi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Michael List invest in?

Michael List invests primarily in Machine Learning, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Michael List last invest?

The most recent investment recorded for Michael List closed in Oct 2023. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co